IntelGenx Technologies, a Canada-based drug delivery company, has appointed Bernd Melchers to its board of directors.
Subscribe to our email newsletter
Mr Melchers will replace David Coffin-Beach who resigned from the board of directors in March 2009 for personal reasons.
Most recently, Mr Melchers was global CFO of the Dyneion Group in Frankfurt, Germany, a subsidiary of 3M Corporation headquartered in Minnesota.
Previously, Mr Melchers served as the European controller of 3M Medical Markets at the 3M Europe headquarter located in Brussels, Belgium. He retired from his position at the Dyneion Group in 2004 and currently provides property management consulting services to private clients in Germany.
Horst Zerbe, chairman and CEO of IntelGenx, said: “We are very pleased to add the support of Bernd Melchers to our board. His extensive and comprehensive international experience in financial and general management will greatly strengthen the board of directors and the company. At the same time, we wish to thank David Coffin-Beach for his invaluable contributions during his term as a director of this company.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.